Leistritz to Host Pharmaceutical-Nutraceutical Extrusion Seminar
The “hands-on” seminar will be held June 12–13, 2019 and will feature educational sessions and demonstrations in the company’s process laboratory.
Leistritz will be hosting its annual Pharmaceutical-Nutraceutical Extrusion Seminar from June 12–13, 2019 in Clinton, NJ. The seminar will feature sessions on twin-screw extrusion theory and design and “hands-on” demonstrations at the company’s process laboratory.
Specific session topics will include the following:
- Twin screw extrusion theory and design
- Downstream systems: pelletizing, tubes, filaments, films, and unique shape extrusion
- Die design, rheological characterization, and computer modeling
- Single screw extrusion theory and design
- Upstream equipment designs for feeding, material handling, and containment
- Scale-up of the extrusion process: R&D, pilot scale, and production
- Cleaning and maintenance of extrusion equipment in a cGMP environment
- Equipment and process validation practices and documentation
- Foaming and co-extrusion.
Demonstrations include:
- Nano-16 twin screw extrusion system processing 50-gram batch samples
- Film/lamination extrusion system for transdermal and dissolvable film applications
- Foaming of an extrudate via carbon dioxide injection
- Hot-face die cutting of nutritional products
- 3D filament and tube extrusion
- Screw assembly/disassembly procedures.
Classroom sessions will be held at the Holiday Inn Select in Clinton, NJ, and extrusion demonstrations will be held at the Leistritz Process Laboratory. For more information contact May Zaw at 908.685.2333 x614 or e-mail mzaw@leistritz-extrusion.com.
Source: Leistritz
Benuvia Granted GMP Certification by Brazil National Health Surveillance Agency
March 14th 2025The certification allows Benuvia to produce pharmaceutical products for companies, either local to Brazil or international, that may be looking for compliant and high-quality production capabilities in the Brazilian pharmaceutical market.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
